• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    5-(Dihydroxyphenoxy)-1H-tetrazoles and their salts are used as non-nutritive sweeteners. These novel compounds are prepared by demethylation of the corresponding 5-(dimethoxyphenoxy)-1H-tetrazoles.
    公开号:SU1066461A3
    申请号:SU813248003
    申请日:1981-02-20
    公开日:1984-01-07
    发明作者:Ли Гарбрект Вильям
    申请人:Эли Лилли Энд Компани (Фирма)；
    IPC主号:
    专利说明:

    PRI me R B. 5- (2,6-dimethoxyphenokea) -1H-tetrazole. By the same procedure as in Example A, 5- (2, b-dimethoxyphenoxy) -1H-tetrazole was prepared using 2,6-dimethoxyphenol as a starting material. The resulting product, 5- (2,6-dimethoxyphenoxy) -1H-tetrazole, has a melting point of 180-182 ° C, yield 62 g (87% of the theoretical). The CMS determined by the titration method is 266 (according to theory 222). Other 5-dimethoxyphenoxy-1H-tetrazoles, such as 5- (2,4 and 2,5-dimetho-syphenoxy) -1H-tetrazole and 5- (3,4- and 3,5-dimethoxyphenoxy) -1H, are prepared by the method described above. -tetrazol. Target products. Some isomers of 5- (dioxyphenoxy) -1H-tetrazole compounds of formula (I) are formed as a mixture with other isomers. Due to the presence of the hydroxy group in the ortho position, isomerization proceeds between 5- (2,3-dihydroxyphenoxy) -1H-tetrazal and 5- (2,6-dioxyphenoxy -1H-tetrazap and between 5- (2,4-dioxyphenoxy) - 1H-tetrazole and 5- (2, 5-dioxyphenoxy-1H-tetrazole. A mixture of 2,3- and 2,6-isomers can be obtained by the method described in example 1. A mixture of 2,3- and 2,6-isomers is formed in In the case when either 5- (2,3-dimethoxyphenoxy) -1H-tetrazole or 5- (2,6-dimethoxyphenoxy) -1H-tetrazap is used as the starting compound. In a protic solvent, such as a solvent, for destruction The complex of aluminum and product extraction, isomers are tautomers. Water and lower alcohols are preferred solvents. The ratio of 2.3 isomers to 2,6 isomers in solution is approximately 40:60 to 60:40. If isomers crystallize from an aqueous solution, the ratio of 2,3-isomers to 2,6-isomers is about 75:25, since the 2,3-isomer is less soluble than the 2,6-isomer and crystallizes first. A dry equilibrium mixture of two isomers can also be obtained by spray drying or evaporating a solution of a mixture of two isomers under vacuum after heating the solution for several hours. Example 1. 5- (2,3-dioxyphenoxy) -1H-tetrazole and 5- (2,6-dioxyphenoxy) -1H-tetrazole. A mixture of 22 g of 5-C2,3-dimethoxyphene si) -1H-tetrazole or 5- (2,6-dimes of syphenoxy) -1H-tetrazole, 40 g of anhydrous gshyuminium chloride and 300 m of benzene is heated at 60 ° C for 2 hours under conditions intensive mixing. The reaction mixture is decomposed by carefully adding 200 ml of aqueous methanol (30% methanol) in order to isolate the target product from the complex based on aluminum chloride. mini The product is extracted with ethyl acetate. The ethyladetate is evaporated, the residue is dissolved in 15 ml of hot water. After that, the residue is treated with activated carbon, filtered and cooled. The desired product is obtained as colorless crystals with a melting point of 1952 ° C in the amount of 9.5 g (49% yield). The results of studies using 13 C HNJP, elemental analysis, titration, and high pressure liquid chromatography allow the product to be identified as a mixture of 5- (2,3-dioxyphenoxy) -1H-tetrazole and 5- (2,6-dioxymethoxy) -1H-tetrazole . Titration with base in 66% dimethylformamide led to the following results: pCs 5.04 and 11.87, CMS 200 (194 according to theory). Calculated: N 28.9 C: NbOz1T Found: N 28.44 Example 2. 5 - (. 3, 5-Dioxyphenoxy) -1H-tetrazole. A mixture of 38.3 g of 5- (3, .5-dimethoxyphenoxy) -1H-tetrazap, 68. g of anhydrous aluminum chloride and 400 g of benzene was boiled for 1.5 hours. To the mixture of aluminum chloride, slowly add a mixture of 150 ml water and 30 ml of methanol. Then the solution is stirred and cooled. The aqueous layer was separated and extracted with ethyl acetate. After evaporation of the ethyl acetate, the resulting product is crystallized from water. Product weight - 5- (3,5-dioxyphenoxy) -1H-tetrazole - 28.2 g, melting point 191-193 C. Calculated: N 24.3 Found: II 24.25 Example 3. 5- (2.3 -dioxyphenoxy) -1H-tetrazole and 5- (2,6-dioxyphenoxy) -1 and tetrazole. . A mixture of 21.1 g of Zil is prepared with 100 ml of collidine. 10 g of 5- (2,6-dimethoxyphenoxy) -1H-tetrazole is added to this mixture with stirring under a nitrogen atmosphere. The mixture was heated under reflux for 18 hours, then cooled. 400 ml of water are added, then acidified with concentrated hydrochloric acid. The reaction mixture is extracted three times with ethyl acetate, dried, decolorized, filtered and evaporated, resulting in 4.5 g of yellow syrup. Product examined by method
    those. It is a mixture of 5 - (, 2, 6-dioxyphenoxy) -1H-tetrazole and 5- (2, 3-dihydroxyphenoxy) -1H-tetrazspha. A small amount of monomethyl compound was also formed.
    Example 4. 5- {2,3-dioxyphenoxy) -1H-tetrazole and 5- (2,6-dioxyphenoxy) -1H-tetrazole.
    A mixture consisting of 10 g of 5- (2,6-dime: 1 hydroxyphenoxy -1H-tetrazole and 11.0 g of sodium cyanide in 100 ml of dimethyl sulphoxide is heated at 170-180 ° C for 5 hours. The reaction mixture is cooled to room temperature and left to stand for 16 hours. The reaction mixture is then diluted with four times the volume of water, acidified with concentrated Hci, extracted with ethyl acetate, dried and evaporated, resulting in 19.6 g of syrup. The presence of 5- (2,3-dioxyphenoxy) was identified by means of HPLC. ) -1H-tetrazole and 5- (,, 6-: 1iokyiphenoxy) -1H-tetrazole. Some amount was also formed GUSTs lonometilnogo compound.
    Example 5. 5- (2, 3-dioxyphenoxy) -1H-tetrazole and 5- (2,6-dioxyphenoxy) t1H tetrazole ,.
     250 ml of chloroform are dried for 16 hours. The reaction was allowed to proceed under substantially anhydrous conditions. To a mixture of 6.6 g of hexamethyldisylang, 22.9 g of 1 and ml of snoroform, was added in one portion .10 p of 5- (2, 6-dimethoxyphenoxy) -1H-tetrazole. The reaction mixture is heated to reflux temperature for 22 h. The reaction mixture is hydrolyzed with 200 MP of water, extracted with chloroform and then with water. The extracts are combined, extracted twice with ethyl acetate, once extracted with water, dried and evaporated, resulting in 12 g of a dark syrupy substance. The method of ZhHV identified 5- (2,3-dioxyphenoxy) -1H-tetrazole and 5-12,6-dioxy-. phenoxy) -1H-tetrazole.
    Example 6. 5- (2,3-dioxyphenoxy) -1H-tetrazal and 5- (2,6-dioxyphenoxy) -1H-tetrazole.
    A mixture containing 2.2 g of 5- (2,3-dimethoxyphenoxy) -1H-tetrazess, 5.9 g of methionine and 13 mp of ketanesulfonic acid is heated at 52 h. The reaction mixture is diluted with four times the volume of water, extracted twice with ethyl acetate, dried and evaporated, resulting in a gain of 1.86 g of a white solid. The HOSVD method showed the presence of 5- (2, 3-dioxyphenoxy} -1H-tetrazole and 5- {2,6-dioxyphenoxy) -1H -TeTrazole ..
    Example 7. 5- (2,3-dioxy-phenoxy) -1H-tetrazal and 5- (2,6-dioxyphenoxy) -1H-tetrazole.
    The editing was carried out under essentially anhydrous conditions. For this, methylene chloride was dried before use. Methylene chloride in the amount of 350 ml was cooled in an acetone bath with dry ice to -60 ° C and 25.0 IWg was added. To this mixture was added 11.0 g of 5- (2,6-dimethoxyphenoxy) -1H-tetrazole with stirring. Stirring is continued for 1.5 h, then the mixture is hydrolyzed 200 ml
    30% methanol. The reaction mixture is boiled at 36 ° C for 2 hours. After that, the organic solvents are distilled off, the remaining aqueous mixture is extracted with ethyl acetate, dried and evaporated, resulting in 2 g of a white solid. The method of identified 5- (2,3-dioxyphenoxy) - 1H-tetrazole and 5- (2,6-dioxyphenoxy) -1H-tetrazol.
    . The salts of 5- (dioxyphenoxy) -1H-tetrazole compounds of formula (I) are also effective feeding agents. Due to the acidity of these compounds, both inorganic and organic bases of sufficient basicity can be used to obtain salts. Sodium, calcium, and ammonium ions can be used as inorganic cations, whereas organic bases can be chosen, for example, from aNteHOB and alkaloids. Therefore, the term salt refers to compounds with inorganic and organic cations contained in tetrazole compounds of the formula (.1).
    In particular, water-soluble salts, especially salts containing sodium, calcium and ammonium ions, are preferred, as well as the water solubility property is necessary when using such compounds as sweeteners. The tetrazole salts of the formula (1 are prepared by reacting the tetrazole compound with the selected Base in an appropriate solvent.
    The examples below illustrate methods for the preparation of such salts.
    Example 8. 5- (2,3-dioxyphenoxy) -1H-tetrazole, sodium salt and 5- (2,6-dioxyphenox) -1H-tetrazole, a mixture of sodium salts.
    A solution of 9.7 g of a mixture of 5- (2, 3-dioxyphenoxy) -1H-tetrazole a and 5- (2,6-dioxyphenoxy) -1H-tetrazole and: 4.2% sodium bicarbonate in 100 tm of water is evaporated (concentrated under vacuum The solid residue is
    is a mixture of sodium salts of isomeric tetrazoles, which was established by the methods of elemental analysis and high pressure liquid chromatography. The weight of the residue was 10.8 g, and the melting point was over 300 ° C (with decomposition).
    Calculated: N 25.9
    Sc.% OZN (,
    Found: Y 25.5
    Example 9. 5- (2, 3-dihydroxyphenoxy) -1H-tetrazole, sodium salt.
    A mixture of 9.7 g of 5- (2,3-dioxyphenoxy) -1H-tetrazole and 5- (2,6-dioxyphenoxy) -1H-tetrazole, 4.2 g of sodium bicarbonate and 100 ml of ethanol is boiled until the evolution of the dioxide is complete. carbon and solution formation. After cooling, the crystalline product is separated, collected and dried. The weight of the product was 3.8 g. The melting point (with decomposition) was above. By high pressure liquid chromatography, it is identified as the sodium salt of 5- (2,3-dioxyphenoxy) -1H-tetrazole. When titrated with base in 66% dimethylformamide, the following results were obtained: pCo. 4.77 and 11.71 and kmv 219 (according to the theory 216).
    Example 10. 5- (2,3-dioxyphenoxy) -1H-tetrazole, calcium salt.
    CNiecb 9.7 g of 5- (2,3-dioxyphenoxy -1H-tetrazole and 5- (2, 3-dioxyphenoxy) -1H-tetrazole, 2.5 g of calcium carbonate, 100 ml of ethanol and 25 ml of water are boiled under reflux until the end of carbon dioxide evolution and solution formation. The solution is filtered and then cooled. Thus, 5.5 g of crystalline product is obtained. Using high-pressure liquid chromatography, it was determined that it is a calcium salt of 5-C2,3-dioxyphenoxy ) -1H-tetrazole, the melting point of which exceeds 300 C.
    The sodium and calcium salts of the 2,3-isomer crystallize selectively. Then, if the salt is acidified and quickly processed, o can extract almost 100% of 5- (2,3-dioxyphenoxy) -1H-tetrazole.
    Example 11 (Method for converting salt to 2,3-isomer). 5- (2,3-dioxyphenoxy -1H-tetrazal.
    A mixture of 2.0 g of calcium salt of 5- (2,3-dioxyphenoxy) -1H-tetrazole and 4.0 ml of water is acidified with concentrated hydrochloric acid. The weight of the crystalline precipitate formed was 1.3 g, and the melting point (decomposition) was 198-200 ° C. Using 13 C NMR and HPLC, this substance was found to be 5- (2,3-dioxyphenoxy) -1H-tetrazole.
    Non-nutrient substances of the formula T of the present invention are usually included in tablets or capsules, in this form they are convenient for
    If used with liquid substances (e.g. coffee), they can be added to a separate cup or glass. Non-nutrients of the formula SI.} Can be used in the form
    5 liquid formulations, the appropriate amount of which can be added to solid or liquid food and mixed with it before meals. In addition, non-nutritional: sweeteners of the formula (L.) of the proposed invention are usually prepared as a free-flowing powder, which can then be mixed with an orally acceptable substance. You can also enter active substances of the formula C1)
    5 into pre-prepared mixtures, such as mixtures for cakes, puddings, and food intermediates for home and food (food preparation. In addition, non-nutritional sweeteners can be used in the processing of substances that are orally acceptable from the very beginning or after preparation, for example ham and tobacco products.
    five
    In order for the active substances CI) to give the desired effect of sweetening together with the orally acceptable substances, it is necessary that the non-nourishing sugary substance of the formula (1) get into the oral cavity simultaneously with the orally acceptable substance. Preferably, such a substance and a sweetener are mixed before entering the mouth, but this is optional.
    The amount of active substance of the formula Q) that will provide a sweet taste may
    0 vary widely and depend on the specific diet and purpose of sweetening. Compounds 5- (schoxyphenoxy) -1H-tetrazole of formula (J.) are 100-600 times sweeter than sucrose. 5-C2, 3-dioxyphenoxy-1H-tet5, 1200 times sucrose.
    The sucrose concentrations were compared with different concentration and tetrazole compounds of the formula (I) to determine the relative sweetness
    0 tetrazole. Received the following comparison of sweetness for sucrose on the threshold of sensitivity:
    Compound
    Sucrose
    5- (3-Oksifeioksi) -1H-tetrazole C31
    Mixture of 5- (2, 6-dioxifoxi} -1H tetrazole and 5- (2, 3-doxyphenoxy-1H-tetrazole) Relative sweetness in terms of threshold values for the row FeCo compound
    Evaluation
    1,130
    575
    Evaluation of noxitrazole was as follows;
    Sucrose
    5- (2-Oxyphenoxy) g1H-tetrazal
    5- (4-Oxyphenoxy) 1H-tetrazole
    5- (3-Oxyphenoxy) -1H-tetrazole
    A mixture of 5- (2, 6-dioxyphenoxy -) - 1H-tet
    5- (2, 3-dioxyphenoxy) -1H-tetrazole
    5- (2,3-Dioxyphenoxy) -1H-tetrazole 5- (3,4-Dioxyphenoxy) -1H-tetrazole
    5-C 3,5-Dioxyphenoxy) -1H-tetrazole
    The compounds of the formula Q) can be used as stand alone sweeteners or in conjunction with other sweeteners such as saccharins,
    one
    100 100 200
    600
    1200
    t
    100
    200
    cyclamates, dihydrochalones / monosxyphenoxy-1H-tetrazoles, 5-carbocycloamine tetrazole compounds, and dextroenantiomorphs of 6 N-substituted tryptophan compounds.
    权利要求:
    Claims (1)
    [1]
    The method of obtaining 5- (dioxiphenoxy) -1H-tetrazoles of the formula
    N or mixtures of isomers, or non-toxic, physiologically acceptable salts, characterized in that they carry out the reaction of 5- (dimeth.oxyphenoxy) -1H-tetrazole of the formula with anhydrous aluminum chloride in an amount of 2-5 moles in an inert organic solvent such as benzene, with temperature ^ From room temperature to the boiling temperature of the mixture, followed by hydrolysis of the resulting compound with aqueous 30% methanol or lithium iodide in collidine at the boiling point of the mixture, followed by aqueous hydrolysis of the obtained compound, or sodium cyanide in dimethylsulfoxide at 170-180 ° C or goksametildisilanom and iodine in chloroform at the boiling temperature of the mixture followed by an aqueous hydrolysis of the resulting compound, or methionine and methanesulfonic .. fokislotoy at 'tomperature hydrochloric from room 5 to 75 e C, or methylene chloride > I at - 60 ° С followed by the addition of VVg 5 , holding the reaction ζ mixture at room temperature
    24 h, by hydrolysis with a 30% aqueous solution of methanol * and heating at ζ
    36 °
    With
    With reflux for 2 hours, and if desired, the resulting compounds of the formula (.1! In the form of their salts are isolated.
    类似技术:
    公开号 | 公开日 | 专利标题
    US7935377B2|2011-05-03|Crystals of free |-monatin and use thereof
    JP5113978B2|2013-01-09|Organic amine salt of glutamic acid derivative and use thereof
    US7973070B2|2011-07-05|Monatin hydrate crystals
    EP0117570B1|1986-09-03|Sodium salt of ursodeoxycholic sulphate
    DK153352B|1988-07-11|GLUCOPYRANOSIDO-1,6-MANNITOL, METHOD OF PREPARING THEREOF AND USING IT AS A SUPPLEMENT FOR SUGAR
    SU1066461A3|1984-01-07|Process for preparing 5-|-1h-tetra-zoles, or mixture of their isomers, or non-toxic physiologically acceptable salts
    FI58489C|1981-02-10|ETH SOETNINGSMEDEL INNEHAOLLANDE 1- | -3- | PROPAN-1-ON OCH / ELLER DESS ALKALI METAL SALTER
    EA019689B1|2014-05-30|2-[[[2-[|amino]-4-pyridinyl]methyl]thio]-n-[4-|phenyl]-3-pyridinecarboxamide benzenesulfonate, crystals and polymorphs thereof, and processes for production thereof
    IE45962B1|1983-01-12|4-trifluoromethylbenzoic acid derivatives
    Zienty et al.1947|N-Substituted 2-pyrrolidones
    FI71319C|1986-12-19|FRAMEWORK FOR THERAPEUTIC ADJUSTMENT OF THERAPEUTIC EQUIPMENT
    FI64155B|1983-06-30|NYTT FOERFARANDE FOER FRAMSTAELLNING AV 5-AMINO-1,2,3-TIADIAZOL
    HU209540B|1994-07-28|Process for preparation of 5-methyl-pyrazole derivatives
    HU191714B|1987-03-30|Process for the production of new 4-phenyl-4-oxo-2-butene carboxylic acid-derivatives
    US3968106A|1976-07-06|Process for the manufacture of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide and its use as sweetener
    FI60209B|1981-08-31|FREEZING FOR ALPHA-AMINOBENSYLPENICILLINER OCH SALTER DAERAV
    White1947|Isolation of L-arabinose
    US3515727A|1970-06-02|Substituted tetrazole
    CS208746B2|1981-09-15|Method of making the 3,6-disubstituted-1,2,4-triazin 5-ons
    GB2344996A|2000-06-28|A solid stable aggregate formed from a pyruvate component and a carbohydrate component
    SU455952A1|1975-01-05|The method of cleaning sulfonylamide drugs
    US4356207A|1982-10-26|Sweetening with 5-| tetrazoles
    US3597234A|1971-08-03|Novel substituted tetrazole and use thereof
    RU1806137C|1993-03-30|2-[n,n-dimethyl- n| -ammoniomethyl] -3-| pyridinium chloride showing deratization action
    SU449048A1|1974-11-05|Preparation 2.2 = dialkyl = 5 = hydroxy | = isoindolinium salts
    同族专利:
    公开号 | 公开日
    GR73869B|1984-05-09|
    AT3181T|1983-05-15|
    AU536205B2|1984-04-19|
    US4309446A|1982-01-05|
    DD156531A5|1982-09-01|
    PT72540B|1982-02-10|
    EP0034925A1|1981-09-02|
    BG35897A3|1984-07-16|
    ES499671A0|1982-09-01|
    AR225344A1|1982-03-15|
    FI810525L|1981-08-23|
    IL62175A|1984-08-31|
    ZA811114B|1982-10-27|
    KR840000499B1|1984-04-16|
    IL62175D0|1981-03-31|
    GB2070599B|1983-11-23|
    CS216950B2|1982-12-31|
    PH16216A|1983-08-05|
    KR830005168A|1983-08-03|
    RO81927B|1983-05-30|
    CA1153003A|1983-08-30|
    NZ196309A|1983-11-18|
    EP0034925B1|1983-05-04|
    DK76981A|1981-08-23|
    AU6744981A|1981-08-27|
    JPS56133274A|1981-10-19|
    ES8207162A1|1982-09-01|
    PL125343B1|1983-04-30|
    PT72540A|1981-03-01|
    RO81927A|1983-06-01|
    RO86246A|1985-03-15|
    DE3160213D1|1983-06-09|
    GB2070599A|1981-09-09|
    PL229765A1|1981-09-18|
    RO86246B|1985-04-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3087821A|1961-11-28|1963-04-30|Robert M Horowitz|Dihydrochalcone derivatives and their use as sweetening agents|
    US3294551A|1964-02-24|1966-12-27|Lilly Co Eli|5-carbocyclicaminotetrazole sweetening agents|
    US3597234A|1967-04-14|1971-08-03|Lilly Co Eli|Novel substituted tetrazole and use thereof|
    US3515727A|1967-04-14|1970-06-02|Lilly Co Eli|Substituted tetrazole|
    US3899592A|1968-04-08|1975-08-12|Lilly Co Eli|Sweetening agent|
    US4031265A|1975-06-18|1977-06-21|The United States Of America As Represented By The Secretary Of Agriculture|Method of reducing bitterness in citrus juices|US4356207A|1980-02-22|1982-10-26|Eli Lilly And Company|Sweetening with 5- tetrazoles|
    JPH0655730B2|1987-07-17|1994-07-27|ザヌトラスウィートカンパニー|Strong sweetener|
    KR900701177A|1988-07-12|1990-12-01|원본미기재|High concentration sweetener|
    US5637618A|1990-06-01|1997-06-10|Bioresearch, Inc.|Specific eatable taste modifiers|
    AT322831T|2001-05-23|2006-04-15|Nutricopia Inc|FROZEN NUTRITIONAL MEALS AND METHOD FOR THE PRODUCTION THEREOF|
    CA2458936A1|2001-08-31|2003-03-13|Nutricopia, Inc.|Nutritional frozen dessert and methods of menufacture|
    US20050230459A1|2004-04-16|2005-10-20|Johnson Gregory L|Envelope adhesives with flavors and scents|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US06/123,859|US4309446A|1980-02-22|1980-02-22|5-tetrazoles and use as sweeteners for medical compositions|
    [返回顶部]